Biosergen AB Schedules Extraordinary General Meeting for August 6
Biosergen AB has announced an extraordinary general meeting for its shareholders to be held on August 6, 2026, in Stockholm. The meeting will address company matters.
Biosergen AB will convene an extraordinary general meeting for its shareholders on August 6, 2026, at 16:00. The meeting is scheduled to take place at BAHR Advokatbyrå, located at Birger Jarlsgatan 16, Stockholm.
Shareholders intending to participate must be registered in the company's share register, maintained by Euroclear Sweden AB, as of July 29, 2026. Additionally, shareholders must provide notice of their intention to attend no later than July 31, 2026.
This meeting provides a platform for shareholders to engage with the company's management and vote on essential corporate decisions. Such gatherings are a key component of corporate governance, allowing for transparency and shareholder input.